Front Row Advisors LLC Avanos Medical, Inc. Transaction History
Front Row Advisors LLC
- $282 Million
- Q2 2024
A detailed history of Front Row Advisors LLC transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Front Row Advisors LLC holds 60 shares of AVNS stock, worth $1,399. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60
Previous 60
-0.0%
Holding current value
$1,399
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AVNS
# of Institutions
274Shares Held
42.1MCall Options Held
800Put Options Held
9.2K-
Black Rock Inc. New York, NY7.01MShares$164 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.27MShares$123 Million0.0% of portfolio
-
Rgm Capital, LLC Naples, FL3.17MShares$74 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.58MShares$60.1 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.22MShares$51.7 Million0.03% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $1.08B
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...